“A LEGACY TRIAL FROM TVM MDL 2327” Mass Tort News would like to welcome Jane Akre, as our senior contributor and writer on Women’s Health subjects as well as related litigation. Jane is primarily known as the Editor of Mesh Medical Device News Desk, where she has been providing outstanding real-time reporting on TVM and other dockets that have impacted women for several years. … [Read more...] about ETHICON TVM TRIAL (MDL 2327) STARTS IN CHARLESTON Sutphin vs. Ethicon 2:14-cv-01379
Article Provided by Brenden Leydon Attorney at Wocl Leydon LLC The litigation over the harmful effects of Zantac (generic name is Ranitidine) is just getting underway, and it looks like it will lead to a significant number of cases. What is Zantac/Ranitidine? Ranitidine is an antacid which belongs to a class of drugs known as histamine-2 receptor agonists (H2 blockers). … [Read more...] about Zantac Litigation Overview
Avanir Pharmaceuticals, the maker of Nuedexta, a prescription drug approved to treat a rare neurological condition is earning hundreds of millions of dollars a year by aggressively targeting elderly nursing home residents in “off-label” use, for whom the drug may be unnecessary and now recognized as unsafe. Off-label use is when a company offers and markets a drug for … [Read more...] about Nuedexta: Drug Being Pushed “Off-Label” On Elderly In Nursing Homes = $116 Million Settlement
The FDA missed a deadly corporate marketing campaign–AGAIN! Juul’s popularity was fueled by the company’s social media marketing that featured attractive young people in fun, trendy settings. A report by Stanford University researchers concluded that Juul’s launch marketing was “patently youth oriented” and “subsequently Juul’s … [Read more...] about JUUL: How Big Tobacco bought into a company that killed teens for profit!
(MASS TORT NEWS) U.S. health officials are now finally taking an assertive position regarding women getting breast implants by stating that stronger warnings and more details about the possible risks and complications including links to cancer. Why has there been a multi-year FDA delay on this in the USA? The Food and Drug Administration said that manufacturers should add a … [Read more...] about FDA FINALLY MOVING ON BREAST IMPLANTS: Once again lagging behind the world in healthcare oversight
Profits Before Patients is the FDA-Big Pharma Shared Model “BY REMOVING FDA OVERSIGHT BIG PHARMA WAS ALLOWED TO PROFIT FROM LIES” (October 19, 2019) (MASS TORT NEWS) Starting in 2017 and continuing into the foreseeable future, Big Pharma has been fighting major legal battles related to off-label marketing of drugs for unintended uses. They also engaged in a … [Read more...] about Why Does the FDA Ignore “Off-Label” Drug Marketing While Thousands Die Every Year?